 RTT News |
Boston Scientific's 2Q Beats Street
FOXBusiness Boston Scientific Corp. (BSX) posted second-quarter results that fell from a year ago, but the results topped expectations, as the company struggles to get sales back on track after production of its implantable defibrillators was … Beaten Down Boston Scientific Beats Boston Scientific Beats Estimates as Device Sales Recover Following Recall Boston Scientific Profit Down 38% on Lower Sales |
Related posts:
- US Clears Boston Scientific to Resume Defibrillator Sales – New York Times
- Boston Scientific Faces Sales Hit, But Image Another Issue >BSX – Wall Street Journal
- Analyst: Boston Scientific Suspends Device Sales – New York Times
- Boston Scientific Recall Under Investigation – Wall Street Journal
- Judge Holds Off Boston Scientific Unit Plea in Probe – BusinessWeek
Secured by